Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, February 06, 2017
Strata Oncology, a precision oncology company, has announced an agreement with Epizyme to support patient identification and enrollment for Epizyme's ongoing Phase 2 clinical trial of tazemetostat in patients with relapsed or refractory non-Hodgkins ...
read more
Monday, February 06, 2017
Myoderm has announced the addition of Chief Operating Officer James Lovett. James will work alongside long-time Managing Director Michael Cohen to lead the company on a continued path of growth and global expansion.
read more
Monday, February 06, 2017
Cocoon Biotech, Inc., is a biotechnology company focused on utilizing its silk protein-based drug delivery technology for the development of formulations to treat osteoarthritis and other conditions for which many patients find existing treatments to...
read more
Monday, February 06, 2017
Innomar Strategies, a specialty drug service provider, and a part of AmerisourceBergen, is adding another distribution center and three specialty pharmacies to the company’s existing specialty solutions infrastructure. The new locations will further ...
read more
Wednesday, February 01, 2017
Chiltern has announced the opening of its new process and technology center in Bangalore, India. The new office is a direct result of the company’s continued success and fulfills a need to further enhance its global data capabilities.
read more
Wednesday, February 01, 2017
Patheon has completed the acquisition of a state-of-the-art manufacturing facility in Florence, South Carolina from Roche Holdings, Inc. Patheon has begun integrating the site into the Patheon network.
read more
Wednesday, February 01, 2017
The Pharmaceutical Research and Manufacturers of America (PhRMA) board of directors has elected new officers and welcomed a new member company.
read more
Wednesday, February 01, 2017
OPKO Health has announced that its subsidiary and business unit, GeneDx, is entering into a collaboration with the Deciphering Developmental Disorder (DDD) study led by the Wellcome Trust Sanger Institute.
read more
Tuesday, January 31, 2017
ReachBio Research Labs has announced the launch of their new drug development platform, cellPrism®. The platform is designed to offer biotechnology and pharmaceutical companies a spectrum of customized in vitro assays to assess and evaluate potential...
read more
Tuesday, January 31, 2017
MD Logistics, a third-party logistics firm, announced plans to expand its Indiana operations, creating up to 50 new jobs in 2017.
read more
Saturday, January 28, 2017
Biotest Pharmaceuticals Corporation has announced the relocation of its Gainesville plasma collection center to 2315 NW 13th Street, Gainesville, Florida. The 15,000 square foot state-of-the-art facility officially opened its doors for business on ...
read more
Saturday, January 28, 2017
Vetter has begun operations in its expanded Visual Inspection and Logics Center located in Ravensburg. The enlargement, in which the company invested approximately 100 million euros ($107 million), bundles capacity for final product inspection and ...
read more
Saturday, January 28, 2017
Porton Fine Chemicals, a China-based contract development and manufacturing organization (CDMO) serving the global pharmaceutical industry, has announced that Porton USA, L.L.C., a wholly-owned subsidiary of Porton, has entered into a stock purchase ...
read more
Saturday, January 28, 2017
Mallinckrodt has closed the sale of its global Nuclear Imaging business to IBA Molecular (IBAM) for approximately $690 million before tax, including up-front and contingent considerations and the assumption of long-term obligations.
read more
Aurinia Pharmaceuticals has selected Worldwide Clinical Trials as its Clinical Research Organization (CRO) for the AURORA Phase 3 study of volcosporin for the treatment of active lupus nephritis (LN).
read more